Neuraxis (NRXS) Cash & Equivalents (2022 - 2026)
Neuraxis (NRXS) reported Cash & Equivalents of $4.48 million for Q3 2026, up 2.3% from $4.38 million a year earlier but down 46.2% from the prior quarter.
Powered by 
Analysis
Neuraxis (NRXS) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Neuraxis posted Cash & Equivalents of $4.97 million, up 34.3% from FY2024.
- Cash & Equivalents has a three-year compound annual growth rate of 169.5% (FY2022 to FY2025).
- By year, Cash & Equivalents came in at $3.7 million in FY2024, $78,560 in FY2023 (-69.0%) and $253,699 in FY2022.
- Five-year quarterly Cash & Equivalents spans a low of $51,440 in Q2 2023 and a high of $8.32 million in Q2 2026.
- Year over year, Cash & Equivalents has now increased in each of the last four quarters, with growth averaging 113.6% over the last five quarters.
- Per Business Quant data, the three quarters before Q3 2026 came in at $8.32 million (Q2 2026), $7.08 million (Q1 2026) and $4.97 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 5.46 Bn |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 4.05 Bn |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 5.68 Bn |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 2.98 Bn |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | 3.27 Bn |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 609.00 Mn |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 3.11 Bn |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 2.32 Bn |
| 10 | Neuraxis | 75.94 Mn | 51.10 Mn | 1.76 Mn | 4.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.48 Mn |
| Jun 30, 2026 | 8.32 Mn |
| Mar 31, 2026 | 7.08 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 260,885.00 |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 81,752.00 |
| Dec 31, 2023 | 78,560.00 |
| Sep 30, 2023 | 761,249.00 |
| Jun 30, 2023 | 51,440.00 |
| Dec 31, 2022 | 253,699.00 |
API Access
Neuraxis Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NRXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();